98 related articles for article (PubMed ID: 32322742)
1. Acceptability, adherence, and clinical outcomes, of amoxicillin dispersible tablets versus oral suspension in treatment of children aged 2-59 Months with pneumonia, Kenya: A cluster randomized controlled trial.
Angwa LM; Ouma C; Okoth P; Nyamai R; Kamau NG; Mutai K; Onono MA
Heliyon; 2020 Apr; 6(4):e03786. PubMed ID: 32322742
[TBL] [Abstract][Full Text] [Related]
2. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the use of job aids and user instructions to improve adherence for the treatment of childhood pneumonia using amoxicillin dispersible tablets in a low-income setting: a mixed-method study.
Sarma H; Gerth-Guyette E; Shakil SA; Alom KR; Abu-Haydar E; D'Rozario M; Tariqujjaman M; Arifeen SE; Ahmed T
BMJ Open; 2019 May; 9(5):e024978. PubMed ID: 31152030
[TBL] [Abstract][Full Text] [Related]
4. Understanding key drivers and barriers to implementation of the WHO recommendations for the case management of childhood pneumonia and possible serious bacterial infection with amoxicillin dispersible tablets (DT) in Bangladesh: a qualitative study.
Rahman M; Delarosa J; Luies SK; Alom KR; Quintanar-Solares M; Jabeen I; Ahmed T; Abu-Haydar E; Sarma H
BMC Health Serv Res; 2020 Feb; 20(1):142. PubMed ID: 32093696
[TBL] [Abstract][Full Text] [Related]
5. Optimising adherence to childhood pneumonia treatment: the design and development of patient instructions and a job aid for amoxicillin dispersible tablets.
Ebels K; Faulx D; Gerth-Guyette E; Murunga P; Mahapatro S; Das MK; Ginsburg AS
Arch Dis Child; 2016 Jan; 101(1):57-62. PubMed ID: 26489802
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study.
Patel AB; Bang A; Singh M; Dhande L; Chelliah LR; Malik A; Khadse S;
BMC Pediatr; 2015 Nov; 15():186. PubMed ID: 26577943
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
Block SL; Schmier JK; Notario GF; Akinlade BK; Busman TA; Mackinnon GE; Halpern MT; Nilius AM
Curr Med Res Opin; 2006 Sep; 22(9):1839-47. PubMed ID: 16968587
[TBL] [Abstract][Full Text] [Related]
8. Adherence to oral amoxicillin dispersible tablets in children with community-acquired pneumonia enrolled in clinical trials in Malawi.
Ginsburg AS; May S
Pneumonia (Nathan); 2021 Jun; 13(1):10. PubMed ID: 34167590
[No Abstract] [Full Text] [Related]
9. Comparison of methods to assess adherence to small-quantity lipid-based nutrient supplements (SQ-LNS) and dispersible tablets among young Burkinabé children participating in a community-based intervention trial.
Abbeddou S; Hess SY; Yakes Jimenez E; Somé JW; Vosti SA; Guissou RM; Ouédraogo JB; Brown KH
Matern Child Nutr; 2015 Dec; 11 Suppl 4(Suppl 4):90-104. PubMed ID: 25521188
[TBL] [Abstract][Full Text] [Related]
10. A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years.
Holas C; Chiu YL; Notario G; Kapral D
Clin Ther; 2005 Dec; 27(12):1950-60. PubMed ID: 16507381
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of and adherence to dispersible zinc tablet in the treatment of acute childhood diarrhoea.
Nasrin D; Larson CP; Sultana S; Khan TU
J Health Popul Nutr; 2005 Sep; 23(3):215-21. PubMed ID: 16262017
[TBL] [Abstract][Full Text] [Related]
12. Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets.
Cheng WY; Said Q; Hao Y; Xiao Y; Vekeman F; Bobbili P; Duh MS; Nandal S; Blinder M
Curr Med Res Opin; 2018 Nov; 34(11):1959-1966. PubMed ID: 29701080
[TBL] [Abstract][Full Text] [Related]
13. Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial.
Nduba VN; Mwachari CW; Magaret AS; Park DR; Kigo A; Hooton TM; Cohen CR
Thorax; 2008 Nov; 63(11):999-1005. PubMed ID: 18559367
[TBL] [Abstract][Full Text] [Related]
14. Effect of enhanced feedback to hospitals that are part of an emerging clinical information network on uptake of revised childhood pneumonia treatment policy: study protocol for a cluster randomized trial.
Ayieko P; Irimu G; English M
Trials; 2017 Sep; 18(1):416. PubMed ID: 28877729
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial.
Abdulla S; Sagara I; Borrmann S; D'Alessandro U; González R; Hamel M; Ogutu B; Mårtensson A; Lyimo J; Maiga H; Sasi P; Nahum A; Bassat Q; Juma E; Otieno L; Björkman A; Beck HP; Andriano K; Cousin M; Lefèvre G; Ubben D; Premji Z
Lancet; 2008 Nov; 372(9652):1819-27. PubMed ID: 18926569
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
[TBL] [Abstract][Full Text] [Related]
17. Management of Chest Indrawing Pneumonia in Children Under Five Years at the Outpatient Health Facilities in Nigeria: An Economic Evaluation.
Okafor CE
Appl Health Econ Health Policy; 2021 May; 19(3):429-437. PubMed ID: 33354754
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial.
Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group
Lancet; 2002 Sep; 360(9336):835-41. PubMed ID: 12243918
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59 months old with non-severe pneumonia: a randomized controlled trial.
Vilas-Boas AL; Fontoura MS; Xavier-Souza G; Araújo-Neto CA; Andrade SC; Brim RV; Noblat L; Barral A; Cardoso MR; Nascimento-Carvalho CM;
J Antimicrob Chemother; 2014 Jul; 69(7):1954-9. PubMed ID: 24648506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
